PX1 Research provides certified, high-purity Tirzepatide 15mg strictly for in vitro, biochemical, and preclinical laboratory applications. Engineered to meet rigorous analytical standards, our lyophilized peptide formulations ensure reproducibility across advanced metabolic and receptor-binding experiments.
PX1 Research provides certified, high-purity Tirzepatide 15mg strictly for in vitro, biochemical, and preclinical laboratory applications. Engineered to meet rigorous analytical standards, our lyophilized peptide formulations ensure reproducibility across advanced metabolic and receptor-binding experiments.
To buy Tirzepatide 15mg for laboratory investigation, verified research institutions require high-purity, lyophilized compounds backed by lot-specific Certificate of Analysis (COA) documentation. PX1 Research supplies domestic, research-grade Tirzepatide synthesized under strict Quality Management protocols, verified via High-Performance Liquid Chromatography (HPLC) and Mass Spectrometry (MS) to exceed 99% purity for precision in vitro and animal studies.
Researchers evaluating dual-acting metabolic compounds require exact mass uniformity and minimal endotoxin presence to ensure uncompromised assay integrity. Our 15mg vial format allows laboratories to establish consistent working stock solutions across multi-phase experimental designs while utilizing standardized analytical reagents.
Tirzepatide is a novel synthetic 39-amino-acid peptide engineered to exhibit potent dual agonism at both the glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. The sequence is derived from the native GIP structure but modified with C-terminal acyl side chains—specifically a C20 fatty diacid moiety attached via a linker—which promotes non-covalent binding to albumin in laboratory buffers and biological matrices.
This structural lipidation extends the terminal elimination half-life in preclinical animal models, allowing sustained receptor engagement without frequent re-administration in longitudinal studies. Molecular weight analysis via electrospray ionization mass spectrometry (ESI-MS) confirms a theoretical mass of approximately 4813.5 Da. The structural integrity of the peptide backbone relies on precise sequence fidelity, which PX1 Research confirms for every production lot.
In cellular binding assays and recombinant receptor models, Tirzepatide displays unique biased agonism. Preclinical studies suggest that while Tirzepatide binds the GLP-1 receptor with an affinity lower than native GLP-1, it demonstrates equal or enhanced potency at the GIP receptor compared to native GIP. This balanced co-stimulation triggers intracellular cyclic adenosine monophosphate (cAMP) accumulation through distinct G-protein coupled signaling pathways.
Through co-activation of GIP receptor pathways alongside classical GLP-1 receptor agonists, Tirzepatide alters downstream signal transduction in pancreatic beta-cell cultures, adipocyte lines, and central nervous system tissue explants. In vitro data indicate that simultaneous engagement of both receptor populations leads to synergistic regulation of lipid storage mechanisms, differential insulin secretion kinetics, and modified glucagon transcription.
Extensive rodent models (including ob/ob, db/db, and diet-induced obesity mouse strains) have been utilized to study the metabolic effects of dual GIP/GLP-1 receptor activation. Literature demonstrates that administration of Tirzepatide in high-fat diet rodent cohorts yields greater reductions in body mass, adiposity, and hepatic lipid accumulation compared to monogenic GLP-1 selective compounds.
In vitro pancreatic islet assays indicate that Tirzepatide enhances glucose-dependent insulin secretion while insulating beta cells against cytokine-induced apoptosis. Furthermore, cell culture models evaluating hypothalamic signal cascades show that dual agonism alters pro-opiomelanocortin (POMC) and neuropeptide Y (NPY) gene expression, explaining the marked attenuation of food intake observed in preclinical behavioral assays.
When designing comparative assays for metabolic research, selecting the appropriate receptor ligand is critical for establishing baseline metrics. Tirzepatide 15mg represents a dual-target standard, contrasting directly with single-target and triple-target peptide analogs in current research.
Monogenic GLP-1 receptor ligands like semaglutide 5mg and liraglutide activate only the GLP-1 signaling axis, providing a classical benchmark for insulinotropic and anorexigenic research. Conversely, next-generation multi-agonist compounds like retatrutide 10mg expand engagement to three distinct targets (GIP, GLP-1, and Glucagon receptors). Evaluating Tirzepatide alongside these compounds within our broader metabolic peptide compounds library allows investigators to dissect the individual contributions of GIP vs. Glucagon receptor signaling in complex poly-agonist experimental setups.
Tirzepatide 15mg is supplied as a sterile, lyophilized cake inside a sealed glass research vial. To reconstitute the compound for in vitro or animal administration protocols, researchers should observe strict aseptic techniques within a laminar flow hood. Bacteriostatic water (0.9% benzyl alcohol) or sterile isotonic saline are standard diluents, depending on the sensitive nature of the target cell assay.
Slowly direct the diluent down the glass wall of the vial rather than spraying directly onto the lyophilized powder. Gently swirl the vial until completely dissolved; do not vortex or aggressively agitate the solution, as shear forces can induce peptide aggregation or secondary structure denaturation. For precise volume-to-concentration calculations, consult our standardized peptide reconstitution guidelines.
Lyophilized Tirzepatide remains stable at -20°C for up to 24 months when protected from moisture and light exposure. Avoid ambient room temperature storage for extended periods prior to reconstitution. Desiccant packs should be kept alongside stored vials to prevent atmospheric humidity from degrading the rubber stopper interface.
Once reconstituted in liquid phase, working aliquots should be refrigerated at 2°C to 8°C and used within 14 to 28 days if prepared with bacteriostatic agents. For long-term liquid stability without preservatives, aliquoting the solution into single-use polypropylene tubes and freezing at -80°C prevents repeated freeze-thaw cycles. Detailed temperature matrices are documented in our guide on lyophilized peptide storage.
The analytical validity of any preclinical trial hinges on compound purity and batch consistency. PX1 Research subjects every batch of Tirzepatide to rigorous analytical testing in ISO 17025 accredited facilities prior to distribution.
Purity is quantified using reverse-phase HPLC (RP-HPLC) with UV detection at 214 nm, ensuring that total peptide purity meets or exceeds 99%. Identity is unequivocally confirmed via electrospray mass spectrometry to verify exact mass. Furthermore, total bacterial endotoxin levels are evaluated using Chromogenic LAL (Limulus Amebocyte Lysate) testing, ensuring endotoxin concentrations remain strictly under defined threshold limits (<0.01 EU/mg) to prevent non-specific immune activation in cellular assays.
PX1 Research operates as a trusted USA-based domestic supplier dedicated exclusively to serving academic institutions, biotechnology firms, and contract research organizations (CROs). All orders ship directly from our California and Arizona fulfillment hubs, offering same-day shipping on orders placed Monday through Friday before 12:00 PM PST.
We maintain transparent analytical standards by publishing lot-specific Certificates of Analysis directly accessible to verified procurement managers. Whether acquiring individual units or establishing wholesale peptide accounts for enterprise-scale screening programs, PX1 Research delivers institutional reliability, uncompromising purity, and dedicated technical support across our complete catalog of research peptides.
What is the primary target of Tirzepatide in research assays?
Tirzepatide acts as a dual agonist at both the glucose-dependent insulinotropic polypeptide (GIP) receptor and the glucagon-like peptide-1 (GLP-1) receptor, engineered to study synergistic metabolic signaling.
What purity level is guaranteed when I buy Tirzepatide 15mg from PX1 Research?
Every lot of Tirzepatide 15mg is verified by third-party HPLC and MS testing to exceed 99% chemical purity, with documentation provided in a public lot-specific COA.
Is Tirzepatide 15mg suitable for human administration?
No. Tirzepatide 15mg supplied by PX1 Research is sold strictly for in vitro laboratory research and preclinical animal studies. It is not intended for human or veterinary medical use, therapeutic treatment, or clinical diagnosis.
How should lyophilized Tirzepatide 15mg be stored upon arrival?
Unopened lyophilized vials should be stored at -20°C in a dry, dark environment. Reconstituted liquids should be kept refrigerated at 2°C to 8°C or aliquoted and stored at -80°C to avoid freeze-thaw degradation.
What diluent is recommended for reconstituting Tirzepatide 15mg?
Bacteriostatic water (0.9% benzyl alcohol) is standard for multi-use research protocols, while sterile 0.9% saline or sterile water for injection (SWFI) is preferred for sensitive cell culture media assays.
Are endotoxin levels tested for this peptide?
Yes. Each batch undergoes LAL endotoxin testing to confirm levels remain below regulatory limits (<0.01 EU/mg), ensuring compatibility with sensitive cell lines and animal tissue.
Where does PX1 Research ship Tirzepatide 15mg from?
All products ship directly from our secure research facilities located in California and Arizona, providing rapid domestic transit and same-day dispatch for weekday orders placed before cutoff times.
What is the difference between Tirzepatide and Semaglutide in preclinical research?
Semaglutide is a selective single agonist at the GLP-1 receptor, whereas Tirzepatide is a dual agonist targeting both GIP and GLP-1 receptors simultaneously, allowing researchers to study dual-pathway metabolic crosstalk.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.